Momenta Pharmaceuticals, Inc. (MNTA) News
Filter MNTA News Items
MNTA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest MNTA News From Around the Web
Below are the latest news stories about Momenta Pharmaceuticals Inc that investors may wish to consider to help them evaluate MNTA as an investment opportunity.
Johnson & Johnson to Buy Drug Maker Momenta Pharmaceuticals for $6.5 BillionIt will reportedly be the largest pharma deal to date in 2020, topping Gilead’s $4.9 billion buy of Forty Seven. |
Momenta Pharmaceuticals leads healthcare gainers; Eyenovia and Galapagos among losersGainers: Momenta Pharmaceuticals (MNTA) +69%. iRhythm Technologies (IRTC) +18%. DarioHealth (DRIO) +16%. Verrica Pharmaceuticals (VRCA) +16%. Avalon GloboCare (AVCO) +15%.Losers: BioMarin Pharmaceutical (BMRN) -33%. Galapagos (GLPG) -23%. Eyenovia (EYEN) -19%. Timber Pharmaceuticals (TMBR) -11%. Scworx (WORX) -10%.... |
J&J buying Momenta in a $6.5B all-cash dealJohnson & Johnson is buying Momenta Pharmaceuticals in a major all-cash deal. Yahoo Finance’s Alexis Christoforous, Brian Sozzi, and Anjalee Khemlani discuss. |
Johnson & Johnson to buy Momenta for about US$6.5 billionJohnson & Johnson said on Wednesday it would buy Momenta Pharmaceuticals Inc for about US$6.5 billion in cash to expand into the area of autoimmune disease treatments. |
Momenta Pharmaceuticals' stock rockets after $6.5 billion buyout deal with Johnson & JohnsonShares of Momenta Pharmaceuticals Inc. undefined rocketed 69% into record territory in premarket trading Wednesday, after the biotechnology company announced… |
Momenta Pharmaceuticals EPS misses by $0.07, beats on revenueMomenta Pharmaceuticals (MNTA): Q2 GAAP EPS of -$0.48 misses by $0.07.Revenue of $6.61M (+27.6% Y/Y) beats by $1.08M.Press Release... |
Momenta Pharmaceuticals, Inc. 2020 Q2 - Results - Earnings Call PresentationThe following slide deck was published by Momenta Pharmaceuticals, Inc. in conjunction with their 2020 Q2 earnings call.... |
Momenta Pharmaceuticals, Inc. (MNTA) CEO Craig Wheeler on Q2 2020 Results - Earnings Call TranscriptMomenta Pharmaceuticals, Inc. (MNTA) Q2 2020 Results Conference Call August 10, 2020 08:30 AM ET Company Participants Patty Eisenhaur - VP, IR and Corporate Communication Craig Wheeler - President and CEO Young Kwon - Chief Financial and Business Officer Santiago Arroyo - Chief Medical Officer Tony Manning - Chief Scientific... |
Momenta Pharmaceuticals (MNTA) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseMomenta (MNTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
Will Momenta Pharmaceuticals (NASDAQ:MNTA) Spend Its Cash Wisely?Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the... |